LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis -

Applications | 2017 | ShimadzuInstrumentation

LC/MS, LC/MS/MS, LC/QQQ

Industries

Clinical Research

Manufacturer

Shimadzu

Go to the library View PDF

Downloadable PDF for viewing

Similar PDF

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis

2017|Shimadzu|Applications

LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…

Key words

antibody, bevacizumab, confirmation, structure, quantitation, nsmol, mrm, human, ftfsldtsk, nsmoltm, accuracy, proteolysis, plasma, drug, chromatograms

LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy –

2018|Shimadzu|Applications

LAAN-A-LM-E138 Application News No. C169 nSMOLTM Antibody BA Kit LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy – nSMOLTM Antibody BA Kit Features Analysis Conditions for Bevacizumab…